Research article summary (published 24 Mar 2004):

Abacavir hypersensitivity reaction predicted by genetic test.

Full Abstract

Researchers in Australia found an accurate test to predict who cannot tolerate Ziagen (abacavir). This is still a research test, not in general use.

Author information

Journal and publication information

Publication Type: Newspaper Article

Journal: AIDS treatment news (AIDS Treat News), published in United States. (Language: eng)

Reference: 2004-Mar; vol (issue 399) : pp 6

Dates: Created 2004/06/02; Completed 2004/06/29; Revised 2004/11/17;

PMID: 15199868, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Cohort Studies Dideoxynucleosides - adverse effects Drug Hypersensitivity - genetics HLA-B Antigens - genetics

HLA-B Antigens - genetics Humans Pharmacogenetics Reverse Transcriptase Inhibitors - adverse effects

Associated Chemicals: Dideoxynucleosides (0) ; HLA-B Antigens (0) ; Reverse Transcriptase Inhibitors (0) ; abacavir (0)

Related articles

These are the highest related articles currently in the database:

• Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility. 9 Mar 2008
• Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience. 28 Nov 2007
• HLA-B*5701 and abacavir hypersensitivity. 30 Oct 2004
• A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. 16 Apr 2007
• Pharmacogenomic biomarkers for prediction of severe adverse drug reactions. 5 Feb 2008
• Cytokine profiling in abacavir hypersensitivity patients. 30 Dec 2007
• High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients. 30 Mar 2008
• Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards. 30 Oct 2007
• Labeling changes for abacavir. 30 Jul 2008
• Abacavir hypersensitivity reaction. 29 Apr 2002

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.